BLADDER CANCER
 
Financial toxicity prevalent with bladder Ca patients
Financial toxicity is prevalent among patients with bladder cancer, according to findings from a cross-sectional study presented at the American College of Surgeons Clinical Congress in San Francisco.
Learn more
ADVERTISEMENT
 
Tecentriq plus chemotherapy extends progression-free survival
“The results… support the use of atezolizumab in combination with chemotherapy as an important new treatment option for patients with untreated metastatic urothelial carcinoma,” says Enrique Grande, MD.
Get the data

 
 
 
MORE FROM UROLOGY TIMES
 
Survival rates appear comparable for robotic, open cystectomy
Pembro shows promising antitumor activity
JOB OPPORTUNITIES